news New study discovers how Parkinson’s-linked protein attacks mitochondria 19 August 2021 | By Anna Begley (Drug Target Review) Researchers have used fruit fly larvae to explore how alpha-synuclein impacts the mitochondria, advancing the study of Parkinson’s disease.
news Photobiomodulation therapy may improve future burn treatments 10 August 2021 | By Anna Begley (Drug Target Review) Photobiomodulation therapy was shown to heal burn injuries faster by triggering the growth protein TGF-beta 1 in mice, potentially improving treatments.
news Nanoparticle flu vaccine shows promise at protecting mice 25 May 2021 | By Victoria Rees (Drug Target Review) Using nanoparticle liposomes, researchers have developed an experimental flu vaccine that has shown success in pre-clinical studies.
news More COVID-19 research on mucosal immune system required, scientists say 30 November 2020 | By Victoria Rees (Drug Target Review) Researchers have said that more COVID-19 studies should focus on the mucous membranes of the nose and mouth, to reveal insights into SARS-CoV-2 immunity.
news Researchers discover α-synuclein clue to treating Parkinson’s 17 January 2020 | By Victoria Rees (Drug Target Review) A study has shown that fruit fly larvae lacking a certain region of the α-synuclein protein did not exhibit Parkinson’s symptoms, indicating a potential target.
news E-coli used as a transport capsule for pneumococcal disease vaccine 1 July 2016 | By Victoria White, Digital Content Producer Researchers have developed an E. coli-based transport capsule designed to help next-generation vaccines do a more effective job than today's immunisations...